Technology and Life Sciences IPO Survey – 2019, Full Year

Access the full survey.

Key Metrics for Recent Technology and Life Sciences Initial Public Offerings

U.S. initial public offerings notched another robust year in 2019 despite bouts of volatility, a number of high-profile technology IPOs that struggled, and a slight drop in deal volume. A total of 108 companies went public in 2019, down from 112 in 2018—which was a particularly strong year for public markets. In particular, the second half of 2019 saw 49 life sciences and technology IPOs, down from the 59 in the first half of 2019.

Key H2 2019 Findings:

  • In the life sciences, 26 companies completed offerings (compared to 34 in H1 2019).
  • In the technology industry, 23 offerings priced (compared to 25 in H1 2019).
  • Two technology and life sciences offerings in H2 2019 had proceeds of more than $1 billion, the largest being SmileDirectClub, which raised $1.3 billion.
  • Pricing conditions continued to be favorable for H2 2019 offerings.

This report analyzes key aspects of initial public offerings (IPOs) for technology and life sciences companies that went public in the second half of 2019. Our IPO Survey was developed for clients, friends and others interested in considering the data surrounding recent IPO activity. Downloading the full report will provide you access to a number of tables and charts that offer a graphical view of key parameters as well as a sense of recent trends.